flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Preventing chronic disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global (KDIGO) Controversies Conference Semaglutides Are Poised to Remake

While the precise duration of delayed gastric emptying caused by GLP-1 agonists remains unclear, the possibility of retained stomach contents at the time of surgery has prompted many anesthesiologists to remain cautious

Lead poisoning among young children in Russia: Concurrent evaluation of childhood lead exposure in Ekaterinburg, Krasnouralsk, and Volgograd

Semaglutide 2.4 mg (Wegovy) and tirzepatide (Zepbound) are FDA-approved for chronic weight management in adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition [3]

Clinician-developed: Selected with guidance from Dr

One of the leading causes of hypothyroidism in the modern world is Hashimotos thyroiditis, an autoimmune disease that generates antithyroid autoantibodies

We pride ourselves on using only the finest ingredients with no fillers, binders, or artificial additives